Oncological results of organ preserving treatment of locally advanced renal cell cancerAuthors: Stakhovsky E. Vitruk I. Voylenko O. Stakhovskyi O.... Т. 13, №4 (52)
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study
Evaluation of the quality of life of patients after surgical interventions for complicated forms of colon cancerAuthors: Kubrak M.A. Zavhorodniy S.M. Danylyuk M.B. Т. 13, №4 (52)
Analysis of complications after radical treatment of rectal cancer. VAC therapy as a new method of problem solvingAuthors: Partykevych Y.D. Maliborska S.V. Т. 13, №4 (52)
Past and present in the diagnosis and treatment of T-cell lymphoma: a brief literature review and clinical case reportAuthors: Rudiuk T.O. Tytorenko I.B. Aleksyk O.M. Kalmykova V.V.... Т. 13, № 3 (51)
Modern approaches to the diagnosis and treatment of lymphoproliferative diseases
Xanthine oxidase superoxide radicals as a prognostic factors in colorectal cancer metastatic diseaseAuthors: Burlaka Ant. Virko S. Yefimenko O. Zemskov S.... Т. 13, № 3 (51)
Indications for hematopoietic cell transplantation for lymphoproliferative blood diseases: current practice in Europe, 2022Authors: Tsyapka O.M. Tushnytskyi O.M. Zalokotska L.V. Savuliak H.R.... Т. 13, № 3 (51)
Usage of indocyanine green in routine practice in surgical oncology
Authors: Khoptiana O. Dobrzhanskyi O. Т. 13, № 3 (51)
Authors: Khoptiana O. Dobrzhanskyi O. Т. 13, № 3 (51)
Morphological studies in determining the histogenesis of lung cancerAuthors: Bolhova L.S. Tuganova T.M. Alekseenko O.I. Т. 13, № 3 (51)
Neoadjuvant chemotherapy in resectable locoregionally advanced squamous cell carcinoma of the oral cavity and oropharynxAuthors: Burtyn O.V. Kravets O.V. Hilka O.O. Smolanka I.I.... Т. 13, № 3 (51)
Treatment of patients with recurrent and metastatic forms of breast cancerAuthors: Ivankova V.S. Baranovska L.M. Stoliarova O.Yu. Ivankova O.M.... Т. 13, № 3 (51)
Prospects for the use of pembrolizumab in the treatment of previously untreated patients with advanced malignant pleural mesotheliomaAuthor:Nemish I.L. Т. 13, № 3 (51)
